French Alps 2030 delivers first report to IOC Executive Board
17 March 2025 - The recently created Organising Committee for the Olympic Winter…
Data of InnoCare’s ICP-488 for the Treatment of Psoriasis Presented at Late Breaking Oral Presentation of 2025 AAD
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025
The post hoc analysis investigated treatment responses in a patient subgroup with…
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting
- Full data from the Phase 3 TRuE-PN1 study, presented today in…
Drs. Jeffrey Lieberman, M.D. and David Sinclair, Ph.D. to PresentThe New Frontier of Longevity Science: Living Well Beyond Your Years at SXSW 2025
AUSTIN, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Renowned neuroscientist, psychiatrist, and…
BigBear.ai Announces Fourth Quarter, And Full Year 2024 Results, And Provides 2025 Outlook
4Q 24 revenue of $43.8 million (4Q 23 $40.6 million) +8% year-over-year…
Microchip Technology to Present at the Raymond James 46 Annual Investors Conference
March 03, 2025 17:44 ET | Source: Microchip Technology Inc. CHANDLER, Ariz.,…
Microchip Technology to Present at the Raymond James 46th Annual Investors Conference
March 03, 2025 16:15 ET | Source: Microchip Technology Inc. CHANDLER, Ariz.,…
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps
TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need…
Alumis Announces Late-Breaker Psoriasis Presentation of 52-week Phase 2 OLE Data for ESK-001 at 2025 American Academy of Dermatology Annual Meeting and Accelerated Topline Phase 3 Data Readout
– Late-breaking oral presentation to highlight 52-week data of ESK-001 in a…